Corneal astigmatism in applanation tonometryMark, H H; Mark, T L · 2003

Case 31-1998Cabot, Richard C.; Scully, Robert E.; Mark, Eugene J.; McNeely, William F.; Ebeling, Sally H.; Cleveland, Robert H.; Mark, Eugene J. · New England Journal of Medicine · 1998

CONGENITAL MICROGNATHIAWANG, MARK K. H.; MACOMBER, W. BRANDON; HEFFERNAN, ANDREW H.; Wang, Mark K. H. · Plastic and Reconstructive Surgery · 1964

A methodology for evaluating environmentsWeiderman, Nelson H; Habermann, A Nico; Borger, Mark W; Klein, Mark H · ACM SIGPLAN Notices · 1987

Ring-enlarging furan annulationsHerrinton, Paul H.; Hopkins, Mark H.; Mishra, Pratibha; Brown, Mark J.; Overman, Larry E. · The Journal of Organic Chemistry · 1987

Pleiotropic effects of type 2 diabetes management strategies on renal risk factorsMuskiet, Marcel H A; Tonneijck, Lennart; Smits, Mark M; Kramer, Mark H H; Heerspink, Hiddo J Lambers; van Raalte, Daniël H · The Lancet Diabetes & Endocrinology · 2015

Case 12-2001Cabot, Richard C.; Scully, Robert E.; Mark, Eugene J.; McNeely, William F.; Shepard, Jo-Anne O.; Ebeling, Sally H.; Ellender, Stacey M.; Peters, Christine C.; Libenson, Mark H.; Yang, Jane M. · New England Journal of Medicine · 2001

GLP-1–Based Therapies Have No Microvascular Effects in Type 2 Diabetes MellitusSmits, Mark M.; Tonneijck, Lennart; Muskiet, Marcel H.A.; Hoekstra, Trynke; Kramer, Mark H.H.; Diamant, Michaela; Serné, Erik H.; van Raalte, Daniël H. · Arteriosclerosis, Thrombosis, and Vascular Biology · 2016